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EXPERIMENTAL 
RESULTS & DISCUSSION 
INTRODUCTION 
3’,5’-cyclic guanosine monophosphate (cGMP) is a crucial second messenger 
molecule involved in signal transduction within cells and diverse physiological 
functions such as neurotransmission. 3’,5’-cyclic adenosine monophosphate 
(cAMP) is another related second messenger which modulates cell growth 
and cellular differentiation in organisms. 
Presently the enzyme-linked immunosorbent assay (ELISA) is the most 
commonly used quantitative method for this type of nucleotides. ELISA 
methods offer high sensitivity and excellent throughput capacity. However, the 
high cost of an ELISA kit and the lack of sufficient specificity are considered a 
drawback. More important problems according to matrix interference with 
ELISA can occur, leading to lower precision and accuracy when measuring 
cGMP and cAMP in several biological samples.  
HPLC/MS methods have been documented [1,2]. In this work a new more 
sensitive HILIC SPE method prior to analysis by negative electrospray 
ionization and tandem mass spectrometry was developed and validated to 
quantify cGMP and cAMP in human blood and animal tissues. Stable isotope-
labeled internal standards, 15N3-cGMP and 
13C10,
15N5-cAMP were added prior 
to the sample preparation to compensate for all sources of variability in the 
analytical methodology used.  
Instrumentation 
HPLC – Waters 2690 Separation Module 
MS – API 3000 triple quadrupole mass spectrometer with Turbo Ion Spray 
Chromatographic conditions 
Column – Zorbax SB-C18, 150 mm x 3.0 mm I.D., 3.5 mm particles 
SPE cartridges – HyperSep Silica SPE Column 500 mg/3 mL 
Mobile phase composition – A: water (0.1% formic acid) 
         – B: 1:acetonitrile/2:methanol/4:water 
Gradient – 0% A to 50% A in 10 min 
Flow rate – 0.35 mL/min 
Column Temperature – 25°C 
Injection volume – 50 µL 
  RESULTS AND DISCUSSION 
Development of a new HILIC SPE sample preparation method 
The hydrophilic nature of the cyclic nucleotides (log P ≤≤ 1) suggests the use 
of an SPE method under aqueous normal phase conditions, i.e. pure polar 
silica particles packed in a cartridge with water as strong eluent. The polar 
cGMP and cAMP will be retained on the column when high amounts of 
organic modifier are used. Elution of the compounds can subsequently be 
done with water, leading to complete metabolite recovery. 
Figure 2: Different steps during HILIC SPE: (A) Condition: 5 mL water; (B) 
Equilibration: 5 mL buffer (5/95 100 mM ammonium formate/acetonitrile); (C) Loading: 
4.2 mL sample/extract; (D) Wash step: 1 mL 10/90 water/acetonitrile; (E) Desorption: 2 
mL water; evaporation and reconstitution in 60 µL water. 
Application: human blood 
200 µL of human blood was spiked with 5 ng/mL of IS 3’,5’-cAMP and IS 3’,5’- 
cGMP in a plastic vial. 600 µL of water (2% acetic acid), 200 µL of buffer (5/95 
100mM ammonium formate/acetonitrile) and 3200 µL of acetonitrile was 
added. The resulting high acetonitrile percentage induced protein 
precipitation. These samples were vortexed for 2 min and centrifuged for 5 
min at 3000 rpm. The supernatant was transferred to the HILIC SPE Column. 
Application: animal tissue 
Also several animal tissues were investigated with this HILIC SPE LC-MS/MS 
method: pancreas, kidney and heart of a rabbit. Two extra peaks appeared for 
the same MRM transitions as 3’,5’-cGMP and 3’,5’-cAMP, assuming to be two 
isomers. Animal extracts were also analysed with a high resolution mass 
spectrometer, confirming these peaks to be respectively 2’,3’-cGMP and 2’,3’-
cAMP.   
The concentration of 3’,5’-cGMP and 3’,5’-cAMP in human blood was 
measured for fifteen healthy patients with the HILIC SPE LC-MS/MS method. 
cGMP concentrations varied between 4.7 – 9.2 ng/mL and cAMP between 0.3 
– 5.4 ng/mL, in good accordance with the literature. 
CONCLUSION 
 
The combination of this new high recovery HILIC SPE sample preparation 
method with sensitive LC-MS/MS analysis allows for the quantification of 
these, from a pharmaceutical point of view, highly relevant messenger 
molecules in human blood and animal tissues. 2’,3’-isomers were detected 
and confirmed with high resolution mass spectrometry. Other real samples 
like urine and plant extracts can be analysed with minimal changes to this 
method. 
Figure 1: Structures of cyclic nucleotides measured in human blood and animal tissues. 
Figure 3: (a) Representative MRM chromatogram of a human blood sample (200 µL) 
after HILIC SPE. Spiked with 5 ng/mL internal standard of 3’,5’-cAMP and 3’,5’-cGMP. 
(b) Specific MRM transitions for cGMP and cAMP. 
Figure 4: MRM chromatograms of: (a) 160 mg rabbit pancreas; (b) 150 mg rabbit 
kidney. Spiked with 50 ng/mL internal standard of 3’,5’-cAMP and 3’,5’-cGMP.  
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